RecruitingNot ApplicableNCT06358664
Caffeine and Cataract After Pars Plana Vitrectomy
The Effect of Caffeine Consumption on Cataract Formation After Pars Plana Vitrectomy: a Comparative Study
Sponsor
Vienna Institute for Research in Ocular Surgery
Enrollment
74 participants
Start Date
Apr 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Assessment of cataract development in patients with regular caffeine consumption and those without caffeine consumption after pars plana vitrectomy.
Eligibility
Min Age: 18 YearsMax Age: 105 Years
Inclusion Criteria5
- Age 18 or older
- Written informed consent
- No previous cataract surgery in the study eye
- Scheduled small gauge vitrectomy with intraoperative gas tamponade (SF6 or C3F8) due to retinal detachment or macular hole repair
- No regular caffeine consumption (drinking not more than one cup of a caffeine- containing beverage \[e.g. coffee, energy drinks\] at a maximum of two days per week during the past year)
Exclusion Criteria6
- Intake of systemic or topical corticosteroids within 3 months before study screening
- Increased risk for postoperative cataract development, for example due to ocular trauma in the history
- Severe cataract (LOCS III grading of any cataract form >2) in the study eye at pre- study screening
- Scheduled phacovitrectomy in the study eye
- Participation in any clinical trial three month before study screening
- Ocular surgeries six month before study screening
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREPars plana vitrectomy
Standard pars plana vitrectomy will be performed
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06358664
Related Trials
Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice
NCT070150342 locations
Dexmedetomidine and Propofol for Sedation in Cataract Surgery.
NCT075561331 location
Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
NCT071264703 locations
Functional IOL Implantation in Patients With Epiretinal Membrane
NCT067197392 locations
Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery
NCT070802291 location